Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
LIVE MARKETS-Retail investors got it right, when will institutions come back?
STOXX 600 up 0.05%ABN, Burberry pop on resultsTrump in the Middle EastNasdaq futures up 0.4%Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com RETAIL INVESTORS GOT IT RIGHT, WHEN WILL ...
Reuters
Wed, May 14
Arbutus Biopharma Corp reports results for the quarter ended March 31 - Earnings Summary
Arbutus Biopharma Corp ABUS.OQ reported a quarterly adjusted loss of 13 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -10 cents. The mean expectation of five analysts for the quarter was for a loss of 10 cents per share. Wa...
Reuters
Wed, May 14
Gain Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Gain Therapeutics Inc GANX.OQ reported a quarterly adjusted loss of 16 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -22 cents. The mean expectation of four analysts for the quarter was for a loss of 18 cents per share. Wa...
Reuters
Wed, May 14
UnitedHealth's CEO Hemsley to get $1 million annual base pay
May 14 (Reuters) - UnitedHealth Group UNH.N CEO Stephen Hemsley will get an annual base salary of $1 million and a one-time $60 million equity award as he returns to the top role at a tough time for the healthcare conglomerate. Hemsley, 72, had led the company for more than a decade until 2017 ...
Reuters
Wed, May 14
Guggenheim downgrades Group 1 Automotive to 'neutral'
** Guggenheim downgrades automotive retailer Group 1 Automotive GPI.N to "neutral" from "buy"; price target unchanged at $426** Says rating change due to mix of premium valuation, potential tariff risk on the business and expected slow sales ** Adds price hike due to tariff will star...
Reuters
Wed, May 14
LIVE MARKETS-Lagging ether soars ahead of bitcoin in May
STOXX 600 down 0.5%ABN, Burberry pop on resultsTrump in the Middle EastNasdaq futures steadyWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com LAGGING ETHER SOARS AHEAD OF BITCOIN IN M...
Reuters
Wed, May 14
Arch Insurance acquires IP for Plover's parametric D&O product
By Henry GaleMay 14 - (The Insurer) - Arch Insurance has agreed to acquire the rights to a parametric securities class action insurance product from startup Plover Parametrics.The Insurer was first to report in April 2024 that Plover had partnered with wholesaler CRC Group to launch Side X, a parame...
Reuters
Wed, May 14
Foghorn Therapeutics Inc. reports results for the quarter ended March 31 - Earnings Summary
Foghorn Therapeutics Inc. FHTX.OQ reported a quarterly adjusted loss of 30 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -59 cents. The mean expectation of six analysts for the quarter was for a loss of 34 cents per share....
Reuters
Wed, May 14
Benitec Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Benitec Biopharma Inc BNTC.OQ reported a quarterly adjusted loss of 24 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.64. The mean expectation of six analysts for the quarter was for a loss of 35 cents per share. Wall S...
Reuters
Wed, May 14
Spring Clean Your Portfolio: 5 Cryptocurrencies to Offload in 2025
After months of volatility and uncertainty in the crypto market, it's time to get back to the basics. Instead of chasing losses or doubling down on underperforming investments, it's time to focus on the best-in-class cryptocurrencies capable of powering your portfolio to a winning year in 2025.With ...
The Motley Fool
Wed, May 14
RPT-BREAKINGVIEWS-Coinbase amplifies crypto’s shiny object syndrome
By Stephen Gandel NEW YORK, May 13 (Reuters Breakingviews) - Crypto is gaining currency. Coinbase COIN.O, which operates an exchange for buying and selling bitcoin and other digital money, will be joining the S&P 500 Index .SPX, depositing decentralized finance into more investment portfolios...
Reuters
Wed, May 14
CalciMedica Inc reports results for the quarter ended March 31 - Earnings Summary
CalciMedica Inc CALC.OQ reported a quarterly adjusted loss of 36 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 1 cents. The mean expectation of three analysts for the quarter was for a loss of 31 cents per share. Wall Stree...
Reuters
Wed, May 14
J.P. Morgan upgrades Forge Global to 'neutral' rating
** J.P. Morgan upgrades private market platform Forge Global FRGE.N to "neutral" from "underweight" rating, citing solid performance in Q1** Brokerage says FRGE's Q1 revenue represents strongest quarter since 2021** JPM expects co's Q2 to be less robust due to ongoing macro u...
Reuters
Wed, May 14
GLOBAL MARKETS-European shares steady, dollar softens on tariff truce, muted inflation
European stocks soft after strong rallyFed cautious on rate cuts due to tariff uncertaintyDollar remains under pressureBy Samuel Indyk and Rocky Swift LONDON/TOKYO, May 14 (Reuters) - European stocks were steady on Wednesday as markets took a breather after a strong rally on easing global trade t...
Reuters
Wed, May 14
Stallion Uranium Announces Failure To File Cease Trade Order
May 14 (Reuters) - Simplify Bitcoin Strategy PLUS Income ETF MAXI.O:STALLION URANIUM ANNOUNCES FAILURE TO FILE CEASE TRADE ORDERSTALLION URANIUM CORP - TSX VENTURE EXCHANGE SUSPENDS TRADING OF STALLION URANIUM SHARES
Reuters
Wed, May 14
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
One of the biggest opportunities in healthcare today centers around genome editing. According to analysts at Grand View Research, the global genome market is expected to expand at a compound annual growth rate of more than 16% until the end of the decade. Stocks involved in gene-editing therapies co...
The Motley Fool
Wed, May 14
Septerna soars on $2.2 billion Novo Nordisk deal
** Shares of drug developer Septerna SEPN.O rise 63.3% to $10.99 premarket** Danish drugmaker Novo Nordisk NOVOb.CO is partnering with SEPN in a deal worth up to $2.2 bln to develop oral treatments for obesity and diabetes, the companies say** Deal includes over $200 million in upfront and near-term...
Reuters
Wed, May 14
U.S. STOCKS ON THE MOVE-KKR, American Eagle Outfitters, Aurora Innovation
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures were flat on Wednesday, following a strong start to the week when a soft inflation reading and a U.S.-China trade truce lifted sentiment, with focus now on more deve...
Reuters
Wed, May 14
This Is the Biggest Risk With Super Micro Computer Stock
Super Micro Computer (NASDAQ: SMCI), also known as Supermicro, has been in the doghouse with investors over the past year. There have been concerns around its financials and the reliability of its numbers after its auditor quit, and there were even worries that it may get delisted for being late fil...
The Motley Fool
Wed, May 14
Dynatrace rises after FY forecasts beat estimates
** Shares of software intelligence company Dynatrace DT.N rise 3.2% to $52.14 premarket after upbeat FY outlook, Q4 results** Co expects FY 2026 adj. EPS to be between $1.56 and $1.59, revenue to be $1.95 bln to $1.97 bln vs. analyst estimates of EPS of $1.54 and $1.94 bln revenue - LSEG data** Co p...
Reuters
Wed, May 14
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free